Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
HKEX:8049
|
CN |
|
Gelum Resources Ltd
OTC:GMRCF
|
CA |
Cash Flow Statement
Cash Flow Statement
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||||||
| Net Income |
39
|
16
|
10
|
12
|
12
|
5
|
19
|
25
|
22
|
43
|
62
|
69
|
95
|
160
|
138
|
167
|
173
|
186
|
175
|
150
|
177
|
197
|
198
|
207
|
|
| Depreciation & Amortization |
3
|
4
|
6
|
7
|
9
|
10
|
11
|
13
|
14
|
13
|
10
|
9
|
13
|
15
|
18
|
19
|
21
|
19
|
21
|
22
|
29
|
34
|
28
|
27
|
|
| Other Non-Cash Items |
(23)
|
(14)
|
22
|
0
|
3
|
5
|
(1)
|
1
|
17
|
7
|
(22)
|
0
|
(36)
|
20
|
21
|
(4)
|
(13)
|
(48)
|
(15)
|
57
|
(1)
|
(5)
|
(1)
|
(22)
|
|
| Cash Taxes Paid |
10
|
8
|
12
|
6
|
9
|
5
|
4
|
4
|
5
|
0
|
0
|
13
|
21
|
19
|
19
|
18
|
22
|
32
|
23
|
26
|
25
|
37
|
60
|
43
|
|
| Cash Interest Paid |
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
2
|
|
| Change in Working Capital |
(17)
|
(24)
|
(23)
|
(7)
|
(6)
|
10
|
(12)
|
1
|
(39)
|
(8)
|
(27)
|
(28)
|
11
|
(145)
|
(25)
|
(59)
|
(34)
|
(19)
|
(49)
|
(78)
|
10
|
(22)
|
91
|
7
|
|
| Cash from Operating Activities |
2
N/A
|
(17)
N/A
|
15
N/A
|
13
-12%
|
18
+38%
|
29
+65%
|
17
-42%
|
41
+137%
|
14
-65%
|
55
+283%
|
23
-59%
|
51
+122%
|
83
+62%
|
49
-40%
|
152
+207%
|
124
-18%
|
147
+18%
|
139
-5%
|
133
-5%
|
151
+14%
|
215
+42%
|
204
-5%
|
316
+55%
|
220
-30%
|
|
| Investing Cash Flow | |||||||||||||||||||||||||
| Capital Expenditures |
(13)
|
(13)
|
(35)
|
(17)
|
(14)
|
(12)
|
(11)
|
(35)
|
(21)
|
(5)
|
(38)
|
(88)
|
(83)
|
(14)
|
(10)
|
(19)
|
(36)
|
(34)
|
(17)
|
(99)
|
(93)
|
(11)
|
(32)
|
(11)
|
|
| Other Items |
1
|
1
|
0
|
0
|
0
|
0
|
6
|
0
|
1
|
1
|
(15)
|
34
|
(26)
|
17
|
(99)
|
(130)
|
(161)
|
(50)
|
(112)
|
(146)
|
(68)
|
(107)
|
141
|
(300)
|
|
| Cash from Investing Activities |
(12)
N/A
|
(12)
+6%
|
(34)
-197%
|
(16)
+53%
|
(14)
+14%
|
(12)
+14%
|
(5)
+57%
|
(35)
-576%
|
(20)
+41%
|
(3)
+85%
|
(53)
-1 597%
|
(54)
-3%
|
(109)
-103%
|
3
N/A
|
(108)
N/A
|
(150)
-38%
|
(197)
-32%
|
(84)
+57%
|
(129)
-54%
|
(245)
-90%
|
(161)
+34%
|
(118)
+27%
|
109
N/A
|
(311)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||||||||
| Net Issuance of Common Stock |
91
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(6)
|
(8)
|
10
|
0
|
(1)
|
(9)
|
7
|
0
|
0
|
(0)
|
0
|
4
|
(3)
|
0
|
(1)
|
(5)
|
0
|
(1)
|
0
|
(2)
|
0
|
0
|
80
|
(8)
|
|
| Cash Paid for Dividends |
0
|
0
|
0
|
0
|
0
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
(5)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(31)
|
(29)
|
(16)
|
(26)
|
(28)
|
(284)
|
(35)
|
|
| Other |
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
23
|
11
|
8
|
11
|
2
|
6
|
25
|
4
|
0
|
1
|
1
|
17
|
18
|
|
| Cash from Financing Activities |
68
N/A
|
(8)
N/A
|
10
N/A
|
0
N/A
|
(1)
N/A
|
(13)
-1 064%
|
4
N/A
|
0
-95%
|
1
+250%
|
2
+186%
|
2
+10%
|
22
+918%
|
8
-66%
|
8
-2%
|
10
+26%
|
(3)
N/A
|
6
N/A
|
(7)
N/A
|
(24)
-256%
|
(18)
+27%
|
(25)
-42%
|
(28)
-10%
|
(186)
-573%
|
(25)
+87%
|
|
| Change in Cash | |||||||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
58
N/A
|
(37)
N/A
|
(10)
+74%
|
(3)
+65%
|
3
N/A
|
5
+70%
|
16
+254%
|
6
-61%
|
(5)
N/A
|
54
N/A
|
(28)
N/A
|
19
N/A
|
(19)
N/A
|
60
N/A
|
53
-12%
|
(28)
N/A
|
(44)
-56%
|
48
N/A
|
(21)
N/A
|
(111)
-432%
|
29
N/A
|
58
+99%
|
239
+309%
|
(116)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||||||||
| Free Cash Flow |
(11)
N/A
|
(30)
-177%
|
(20)
+32%
|
(4)
+82%
|
4
N/A
|
17
+391%
|
6
-67%
|
6
N/A
|
(7)
N/A
|
51
N/A
|
(15)
N/A
|
(37)
-146%
|
(1)
+98%
|
35
N/A
|
142
+302%
|
105
-26%
|
111
+6%
|
105
-5%
|
115
+10%
|
52
-55%
|
122
+133%
|
193
+58%
|
284
+47%
|
209
-27%
|
|